18th of Jun 2021, 13.00 (Swedish time)
Title: Applied machine learning to support chemistry and formulation at AstraZeneca
At AstraZeneca we have been using machine learning for decades to inform drug design. Recent development in data science and AI have enable novel workflows that allows historical data to inform design decisions for denovo drug design, drug substance and drug product development with better accuracy. In this talk I will give a historical overview on ML in drug discovery and describe some of our new applications that utilizing deep learning algorithms. I will give examples from route design, purification and separation science and development of drug delivery systems.
About the speaker: Anders Broo has a PhD in theoretical and physical chemistry from University of Gothenburg, Sweden (1991). After post-doc’s in Uppsala and Florida he returned to Sweden for an assistant and associate professor position at Chalmers University of Technology, Gothenburg, Sweden. Anders has published 48 peer reviewed articles and is co-inventor on 3 patents. The research filed spans from electron transfer, photochemistry of DNA bases, medicinal chemistry, chemical stability and materials chemistry. Since joining AstraZeneca 2001 Anders has lead line organizations in discovery and development and lead drug discovery projects and business change programs. In his current role as head of department he leads the data and digital transformation of the Pharmaceutical Sciences research unit.
18 June, 2021, 13:00
18 June, 2021, 13:45